Nutritional Supplement in Alzheimer's Disease

ID Number 05-1394

Principal Investigator(s)
Mary Sano

Department(s) or Division(s)

Research Entity
Alzheimer's Disease Research Center


The purpose of this study is to discover the effects of a nutritional supplement called RGM and placebo on patients with mild to moderate Alzheimer’s Disease (AD). Research has suggested that damage from cell waste may contribute to the progression of Alzheimer’s disease. RGM is an oral supplement made of the substances resveratrol glucose and malate. In previous studies, this mixture was found to possibly improve test scores in patients with AD. However, RGM has not been proven to affect the progression of Alzheimer’s Disease and is still considered an experimental treatment for AD.

Contact Information
Angelica De La Fuente
(212) 241-0438

Recruiting Patients: No